Patent Search

 
 

Use of anastrozole for the treatment of post-menopausal women having early breast cancer

The invention provides the use of anastrozole, or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for the reduction of the rate of recurrence of cancer in a woman having early breast cancer. The invention further provides the use of anastrozole, or a pharmaceutically acceptable salt thereof, in the preparation of a medicament for the reduction of the rate of a new contralateral primary tumour in a post-menopausal woman having early breast cancer.

Breast cancer associated polypeptide

This invention relates to the histone acetyl transferase protein HBO1 and its use in diagnosis and therapy of breast cancers. Methods and means relating to the diagnosis and treatment of breast cancer are provided.

Treatment of breast cancer

Patients with aggressive breast cancer, including patients with estrogen receptor (ER) negative tumors and/or patients who have a disease-free interval from diagnosis to metastatic relapse of less than 36 months, have greater survival times than by treatment with DPPE and doxorubicin than patients receiving doxorubicin alone. Greater survival times are also achieved in patients receiving more than four cycles of treatment with DPPE and doxorubicin rather than doxorubicin alone. Greater survival times by treatment with DPPE and doxorubicin as compared to doxorubicin alone are further obtained in patients with metastatic breast cancer and who either have had no prior chemotherapy or no prior treatment type.

Method of treating breast cancer

A method of treating breast cancer is disclosed. The method comprises administering an FTI, at least one antihormonal agent (e.g., an aromatase inhibitor, an antiestrogen, and an LHRH analogue), optional chemotherapeutic agents (e.g., Trastuzumab), and optional radiation. For example, the treatment of breast cancer using the FTI and Anastrozole is disclosed. Also disclosed is a method of treating breast cancer using the FTI Anastrozole and Fulvestrant. Also disclosed are pharmaceutical compositions comprising an FTI, at least one antihormonal agent and a pharmaceutically acceptable carrier; and compositions comprising an FTI, at least one antihormonal agent, at least one chemotherapeutic agent, and a pharmaceutically acceptable carrier; and compositions comprising an FTI, at least one chemotherapeutic agent, and a pharmaceutically acceptable carrier.

Glypican-1 in human breast cancer
Compositions and methods for therapy and diagnosis of breast cancer
Mammaglobin, a mammary-specific breast cancer protein
Method of diagnosing breast cancer and compositions therefor
Use of anastrozole for the treatment of post-menopausal women having early breast cancer
Compositions and methods for the therapy and diagnosis of breast cancer
Treatment of breast cancer
Apparatus and method for breast cancer imaging


201 20050165081 Use of anastrozole for the treatment of post-menopausal women having early breast cancer
202 20050147970 Breast cancer associated polypeptide
203 20050119263 Treatment of breast cancer
204 20050119188 Method of treating breast cancer
205 20050118658 Use of ERRalpha phosphorylation status as a breast cancer biomarker
206 20050118291 Formulations and methods for treating breast cancer with Morinda citrifolia and methylsulfonymethane
207 20050113432 Bis(cyanophenyl)methyl-triazole for use in prevention of breast cancer
208 20050100933 Breast cancer survival and recurrence
209 20050095607 Breast cancer signatures
210 20050089518 Prospective identification and characterization of breast cancer stem cells
211 20050080062 Breast cancer treatment regimen
212 20050080055 Method of treating breast cancer with androgen receptor antagonists
213 20050065418 Breast cancer screening
214 20050065333 Breast cancer-associated genes and uses thereof
215 20050064442 Methods for identifying risk of breast cancer and treatments thereof
216 20050053988 Gene expressed in breast cancer and methods of use
217 20050053958 Methods for identifying risk of breast cancer and treatments thereof
218 20050042700 Compositions and methods for monitoring breast cancer treatment
219 20050042642 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
220 20050038339 Ultrasonic treatment of breast cancer
221 20050037101 Preventative effects of morinda citrifolia on mammary breast cancer
222 20050031695 Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
223 20050026857 Antisense modulation of breast cancer-1 expression
224 20050019798 Methods to predict death from breast cancer
225 20050014208 Method and kit for diagnosing or controlling the treatment of breast cancer
226 20050009033 Breast cancer genes
227 20050002900 Method of treating estrogen responsive breast cancer
228 20040266704 Method comprising irinotecan for treatment of breast cancer
229 20040265895 Methods and compositions in breast cancer diagnosis and therapeutics
230 20040260142 Method for intraoperative radiation treatment of breast cancer
231 20040259114 Coactivators in the diagnosis and treatment of breast cancer
232 20040254444 Use of MRI to screen normal risk, asymptomatic individuals for breast cancer
233 20040253267 Biological compositions and methods for treatment of breast cancer
234 20040249144 Regulated breast cancer genes
235 20040241160 Vegfr-1 antibodies to treat breast cancer
236 20040235956 Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
237 20040224363 IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer
238 20040224347 Methods for identification, diagnosis, and treatment of breast cancer
239 20040214179 Breast cancer prognostics
240 20040209290 Gene expression markers for breast cancer prognosis
241 20040203023 Proteins, genes and their use for diagnosis and treatment of breast cancer
242 20040192726 Farnesyl protein transferase inhibitors for treating breast cancer
243 20040191819 Expression profiles for breast cancer and methods of use
244 20040167399 Breast cancer detection system
245 20040167170 Methods of preventing breast cancer
246 20040152144 Novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
247 20040151724 Antibody fab fragments specific for breast cancer
248 20040151666 Rodent mammary window for intravital microscopy of orthotopic breast cancer and related method
249 20040146862 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
250 20040142490 Method of using estrogen-related receptor gamma (ERRgamma) status to determine prognosis and treatment strategy for breast cancer, method of using ERRgamma as a therapeutic target for treating breast cancer, method of using ERRgamma to diagnose breast cancer, and method of using ERRgamma to identify individuals predisposed to breast cancer

Copyright © 2006 - 2015 Patent Information Search